Microba
MAP.AXMicroba Life Sciences Limited Price (MAP.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
409,858,784
(23.0844)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Microba Life Sciences LimitedCurrency: AUD
| YEAR | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
1,828,155.00
+0% |
2,909,026.00
+59% |
3,732,443.00
+28% |
4,688,645.00
+26% |
5,420,136.00
+16% |
12,090,055.00
+123% |
|||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 4,318,251.00 | 6,961,810.00 | 9,037,125.00 | 2,322,930.00 | 12,193,069.00 | 20,672,257.00 | |||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
-2,490,096.00
+0% |
-4,052,784.00
+63% |
-5,304,682.00
+31% |
2,365,715.00
-145% |
-6,772,933.00
-386% |
-8,582,202.00
+27% |
|||||||||||||
| Gross Profit Ratio | (-1.36%) | (-1.39%) | (-1.42%) | (0.50%) | (-1.25%) | (-0.71%) | |||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 163,272.00 | 1,539,419.00 | 5,383,823.00 | 9,337,113.00 | 10,836,162.00 | |||||||||||||
| General and Administrative | 1,100,132.00 | 1,976,673.00 | 821,978.00 | 8,572,940.00 | 7,809,365.00 | 12,178,718.00 | |||||||||||||
| Selling, General & Admin... | 2,298,957.00 | 3,190,078.00 | 2,726,266.00 | 9,113,653.00 | 4,120,078.00 | 12,965,063.00 | |||||||||||||
| Selling & Marketing Exp... | 317,849.00 | 224,708.00 | 338,222.00 | 540,713.00 | 692,707.00 | 786,345.00 | |||||||||||||
| Depreciation and Amortiz... | 765,184.00 | 1,091,050.00 | 1,218,079.00 | 1,542,862.00 | 1,641,831.00 | 2,870,274.00 | |||||||||||||
| Other Expenses | 0.00 | 0.00 | 0.00 | 4,816,603.00 | 3,080.00 | -17,895,798.00 | |||||||||||||
| Total Operating Expenses | 2,298,957.00 | 3,353,350.00 | 4,265,685.00 | 18,637,779.00 | 13,454,111.00 | 5,905,427.00 | |||||||||||||
| Cost and Exponses | 6,617,208.00 | 10,315,160.00 | 13,302,810.00 | 20,960,709.00 | 25,647,177.00 | 38,881,423.00 | |||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-4,789,050.00
+0% |
-7,406,130.00
+55% |
-9,570,370.00
+29% |
-11,452,892.00
+20% |
-20,227,040.00
+77% |
-26,842,911.00
+33% |
|||||||||||||
| Operating Income Ratio | (-2.62%) | (-2.55%) | (-2.56%) | (-2.44%) | (-3.73%) | (-2.22%) | |||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 68,297.00 | 101,583.00 | 101,711.00 | 49,551.00 | 878,049.00 | 1,004,728.00 | |||||||||||||
| Interest Expenses | 24,028.00 | 36,965.00 | 23,456.00 | 8,307.00 | 60,412.00 | 69,221.00 | |||||||||||||
| Total Other Income/Exp... | 68,190.00 | 748,943.00 | 2,046,618.00 | 4,810,865.00 | 1,461,012.00 | 6,853,122.00 | |||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -4,023,869.00 | -5,529,171.00 | -6,282,217.00 | -9,863,051.00 | -17,066,871.00 | -17,100,916.00 | |||||||||||||
| EBITDA ratio | (-2.20%) | (-2.17%) | (-2.24%) | (-2.11%) | (-3.43%) | (-1.41%) | |||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -4,720,860.00 | -6,657,187.00 | -7,523,752.00 | -11,461,199.00 | -18,769,112.00 | -19,989,789.00 | |||||||||||||
| Income Before Tax Ratio | (-2.58%) | (-2.29%) | (-2.02%) | (-2.44%) | (-3.46%) | (-1.65%) | |||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 12,969.00 | -6,520.00 | 1.00 | 9,230.00 | -6,088,900.00 | -51,304.00 | |||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -4,733,829.00
+0% |
-6,650,667.00
+40% |
-7,523,752.00
+13% |
-11,470,429.00
+52% |
-12,680,212.00
+11% |
-19,938,485.00
+57% |
|||||||||||||
| Net Income Ratio | (-2.59%) | (-2.29%) | (-2.02%) | (-2.45%) | (-2.34%) | (-1.65%) | |||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -0.02 | -0.02 | -0.03 | -0.04 | -0.04 | -0.05 | |||||||||||||
| Diluted EPS | -0.02 | -0.02 | -0.03 | -0.04 | -0.04 | -0.05 | |||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 290,710,458.00 | 290,710,458.00 | 290,710,458.00 | 290,710,458.00 | 332,990,078.00 | 409,858,784.00 | |||||||||||||
| Diluted Share Outstanding | 290,710,458.00 | 290,710,458.00 | 290,710,458.00 | 290,710,458.00 | 332,990,078.00 | 409,858,784.00 | |||||||||||||